Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy

  1. Hernando Cubero, J.
  2. Grande, E.
  3. Jimenez Fonseca, P.
  4. Villabona, C.
  5. Trigo Perez, J.M.
  6. Martinez Trufero, J.
  7. Pajares Bernad, I.
  8. Lopez, C.
  9. Alonso, T.
  10. Biarnes, J.
  11. RamónY Cajal, T.
  12. Duran, M.
  13. Grau, J.J.
  14. Arevalo Lobera, S.
  15. Mesia Nin, R.
  16. Llanos, M.
  17. Dalmau Portulas, E.
  18. Alvarez, C.
  19. Zafon, C.
  20. Capdevila, J.
Revista:
Annals of oncology : official journal of the European Society for Medical Oncology

ISSN: 1569-8041

Ano de publicación: 2018

Volume: 29

Páxinas: viii476

Tipo: Artigo

DOI: 10.1093/ANNONC/MDY293.022 GOOGLE SCHOLAR lock_openAcceso aberto editor

Obxectivos de Desenvolvemento Sustentable

Fonte de datos: Scopus